Found: 58
Select item for more details and to access through your institution.
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The impact of storage on extracellular vesicles: A systematic study.
- Published in:
- Journal of Extracellular Vesicles, 2022, v. 11, n. 2, p. 1, doi. 10.1002/jev2.12162
- By:
- Publication type:
- Article
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
- Published in:
- European Journal of Immunology, 2016, v. 46, n. 3, p. 701, doi. 10.1002/eji.201545950
- By:
- Publication type:
- Article
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00030
- By:
- Publication type:
- Article
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.694651
- By:
- Publication type:
- Article
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 6982, doi. 10.3390/ijms21196982
- By:
- Publication type:
- Article
HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.771359
- By:
- Publication type:
- Article
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
- Published in:
- Frontiers in Neurology, 2024, p. 01, doi. 10.3389/fneur.2024.1326506
- By:
- Publication type:
- Article
MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 497, doi. 10.1111/bjh.17357
- By:
- Publication type:
- Article
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.
- Published in:
- Neurorehabilitation & Neural Repair, 2019, v. 33, n. 10, p. 825, doi. 10.1177/1545968319868713
- By:
- Publication type:
- Article
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.
- Published in:
- Scientific Reports, 2016, p. 34503, doi. 10.1038/srep34503
- By:
- Publication type:
- Article
Cytokines Stimulate the Release of Microvesicles from Myeloid Cells Independently from the P2X7 Receptor/Acid Sphingomyelinase Pathway.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00204
- By:
- Publication type:
- Article
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 4/5, p. 512, doi. 10.1177/13524585231155049
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1937, doi. 10.1177/13524585221102158
- By:
- Publication type:
- Article
CSF extracellular vesicles and risk of disease activity after a first demyelinating event.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1606, doi. 10.1177/1352458520987542
- By:
- Publication type:
- Article
Obesity worsens central inflammation and disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1237, doi. 10.1177/1352458519853473
- By:
- Publication type:
- Article
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 11, p. 1405, doi. 10.1177/1352458515621796
- By:
- Publication type:
- Article
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1084, doi. 10.1177/1352458512469698
- By:
- Publication type:
- Article
PD-1/PD-L Axis in Neuroinflammation: New Insights.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.877936
- By:
- Publication type:
- Article
Effects of Isoxazolo-Pyridinone 7e, a Potent Activator of the Nurr1 Signaling Pathway, on Experimental Autoimmune Encephalomyelitis in Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108791
- By:
- Publication type:
- Article
Cerebrospinal fluid, brain, and spinal cord levels of L‐aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model.
- Published in:
- Journal of Neurochemistry, 2023, v. 166, n. 3, p. 534, doi. 10.1111/jnc.15884
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of L‐glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
- Published in:
- Journal of Neurochemistry, 2021, v. 159, n. 5, p. 857, doi. 10.1111/jnc.15518
- By:
- Publication type:
- Article
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67165-9
- By:
- Publication type:
- Article
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 2, p. 222, doi. 10.3390/biom12020222
- By:
- Publication type:
- Article
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
- Published in:
- Clinical Science, 2015, v. 129, n. 4, p. 291, doi. 10.1042/CS20140608
- By:
- Publication type:
- Article
MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis.
- Published in:
- Neuropathology & Applied Neurobiology, 2022, v. 48, n. 2, p. 1, doi. 10.1111/nan.12765
- By:
- Publication type:
- Article
Polarized cells display asymmetric release of extracellular vesicles.
- Published in:
- Traffic, 2021, v. 22, n. 4, p. 98, doi. 10.1111/tra.12775
- By:
- Publication type:
- Article
PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis.
- Published in:
- Neurochemical Research, 2019, v. 44, n. 3, p. 726, doi. 10.1007/s11064-018-2484-0
- By:
- Publication type:
- Article
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 6, p. 813, doi. 10.1002/ana.24235
- By:
- Publication type:
- Article
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
iAstrocytes do not restrain T cell proliferation in vitro.
- Published in:
- BMC Neuroscience, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12868-023-00806-3
- By:
- Publication type:
- Article
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 12, p. 4436, doi. 10.1007/s00415-021-10595-6
- By:
- Publication type:
- Article
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 11, p. 2540, doi. 10.1007/s00415-018-8994-5
- By:
- Publication type:
- Article
Selective loss of microvesicles is a major issue of the differential centrifugation isolation protocols.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83241-w
- By:
- Publication type:
- Article
Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-018-0288-4
- By:
- Publication type:
- Article
Osteopontin Is Associated with Multiple Sclerosis Relapses.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 178, doi. 10.3390/biomedicines11010178
- By:
- Publication type:
- Article
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2058, doi. 10.3390/biomedicines10092058
- By:
- Publication type:
- Article
miR‐21 sustains CD28 signalling and low‐affinity T‐cell responses at the expense of self‐tolerance.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 9, p. 1, doi. 10.1002/cti2.1321
- By:
- Publication type:
- Article
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, p. 1, doi. 10.1177/1756286420970833
- By:
- Publication type:
- Article
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420970833
- By:
- Publication type:
- Article
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
- Published in:
- Frontiers in Molecular Neuroscience, 2024, p. 1, doi. 10.3389/fnmol.2024.1430080
- By:
- Publication type:
- Article
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.
- Published in:
- Molecular Neurodegeneration, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1750-1326-9-56
- By:
- Publication type:
- Article
IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 11/12, p. 1383, doi. 10.1177/13524585231197928
- By:
- Publication type:
- Article
Microvesicles: what is the role in multiple sclerosis?
- Published in:
- Frontiers in Neurology, 2015, v. 6, p. 1, doi. 10.3389/fneur.2015.00111
- By:
- Publication type:
- Article
Constitutive IL-1RA production by modified immune cells protects against IL-1–mediated inflammatory disorders.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 698, p. 1, doi. 10.1126/scitranslmed.ade3856
- By:
- Publication type:
- Article
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis.
- Published in:
- Genes, 2022, v. 13, n. 5, p. 897, doi. 10.3390/genes13050897
- By:
- Publication type:
- Article